↓ Skip to main content
What is this page? Embed badge

Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

Overview of attention for article published in Nature Genetics, December 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs
2 blogs
policy
1 policy source
twitter
2 X users
patent
27 patents
guideline
3 clinical guideline sources

Readers on

mendeley
405 Mendeley
citeulike
6 CiteULike
So far, Altmetric has seen 3 Guidelines that reference this research output.

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Clinical guideline published by United States and Canadian Academy of Pathology (USCAP) on

The United States and Canadian Academy of Pathology (USCAP) is dedicated to advancing pathology through education and research. It offers a range of continuing medical education (CME) courses, both online and in-person, and supports the pathology community with resources and networking opportunities.

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Clinical guideline published by European LeukemiaNet (ELN) on

The European LeukemiaNet (ELN) is a collaborative network comprising 220 centers across 45 countries, uniting over 1000 researchers and clinicians. Its mission is to enhance leukemia research through integration of leading trial groups and interdisciplinary partners, fostering advancements in treatment and care.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.